Showing results (371-380 of 618) with videos related to
Sort By:
Pageof 62
Biosensors & Bioelectronics|November 13, 2003
First human experiments with a novel non-invasive, non-optical continuous glucose monitoring systemA Caduff, E Hirt, Yu Feldman, et al.Diabetologia|August 1, 1989
Effect of 8 hours of hyperinsulinaemia on haemostatic parameters in healthy manG Mauricio-Leguizamo, L Heinemann, R E Scharf, et al.Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|July 15, 1975
[Screening and early diagnosis of disorders of the arterial blood supply]H Heine, H Schmidt, M Kornotzki, et al.Endocrine|March 18, 2017
Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technologyA Pfützner, D Klonoff, L Heinemann, et al.Seminars in Thrombosis and Hemostasis|December 2, 1998
Resistance to activated protein C in women using oral contraceptivesM Spannagl, A Dick, A Assmann, et al.Human Gene Therapy|March 10, 2001
Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3A Brüning, T Köhler, S Quist, et al.Dalton Transactions (Cambridge, England : 2003)|December 20, 2018
Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligandsJana Hildebrandt, Ralf Trautwein, Daniel Kritsch, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 23, 2012
Combined staging at one stop using MR mammography: evaluation of an extended protocol to screen for distant metastasis in primary breast cancer - initial results and diagnostic accuracy in a prospective studyM Dietzel, R Zoubi, H P Burmeister, et al.Human Reproduction (Oxford, England)|April 1, 1996
The Acridine Orange test: a clinically relevant screening method for sperm quality during infertility investigation?W Eggert-Kruse, G Rohr, H Kerbel, et al.Journal of Cancer Research and Clinical Oncology|April 12, 2013
p53-autoantibody may be more sensitive than CA-125 in monitoring microscopic and macroscopic residual disease after primary therapy for epithelial ovarian cancerNorman Häfner, Kristin Nicolaus, Stefanie Weiss, et al.Pageof 62